Literature DB >> 24838050

The effect of MTHFR C677T polymorphism on type 2 diabetes mellitus with vascular complications in Chinese Han population: a meta-analysis.

Dan Zhang1, Yijun Zhou, Lingling Han, Hongmei Ji, Jia Li.   

Abstract

Methylenetetrahydrofolate reductase plays an important role in folate metabolism. Individuals who are type 2 diabetes mellitus have greatest risk for the development of vascular complications. The results of studies which assessed the association between MTHFR C677T polymorphism and T2DM with vascular complications were inconsistent in the Chinese Han population. The purpose of this meta-analysis was to assess the associations between MTHFR C677T polymorphism and T2DM with vascular complications in the Chinese Han population. We collected all relevant articles on MTHFR C677T polymorphisms and T2DM with vascular complications in the Chinese Han population in multiple electronic databases which were searched to December 2013. Fixed-effects and random-effects meta-analyses were performed to assess the odds ratios (ORs). Stratified Analysis, sensitivity Analysis and publication bias were examined. A total of 1984 diabetic patients with vascular complications and 1703 single diabetic patients were found in meta-analysis. There was a significant association between MTHFR C677T polymorphisms and T2DM with vascular complications under recessive genetic model, dominant genetic model, homozygous genetic model, heterozygous genetic model and allele comparison. Sensitivity analysis indicated that the overall result was dependable. Our meta-analysis suggests the MTHFR C677T polymorphisms is associated with T2DM with vascular complications in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838050     DOI: 10.1507/endocrj.ej14-0071

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant.

Authors:  Dan Zhang; Bo Zhu; Wei Zhang; Wei Wang; Dan Guo; Ligang Yang; Lu Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

2.  Synergistic Effect of the MTHFR C677T and EPHX2 G860A Polymorphism on the Increased Risk of Ischemic Stroke in Chinese Type 2 Diabetic Patients.

Authors:  Liang Ma; Yongwei Jiang; Xiaomu Kong; Meihua Yan; Tingting Zhao; Hailing Zhao; Qian Liu; Haojun Zhang; Yongtong Cao; Ping Li
Journal:  J Diabetes Res       Date:  2017-03-20       Impact factor: 4.011

3.  Association of Kaphaja and Kapha-Pittaja Prakriti and methylenetetrahydrofolate reductase C677T allele with type 2 diabetes.

Authors:  Archana Gupta; Akhtar Ali; Priyadarshini Tewari; Neeraj Kumar Agrawal; Rashmi Patel; Parameswarappa Shivappa Byadgi
Journal:  Ayu       Date:  2018 Jul-Sep

Review 4.  Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.

Authors:  Shanel Raghubeer; Tandi E Matsha
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

5.  Methylenetetrahydrofolate reductase C677T gene polymorphism and the association with dyslipidemia in type 2 diabetic Palestinian patients.

Authors:  Muawiyah Elqadi; Khaled Eweidat; Mosa Abu Sabha; Asil Yagmour; Anas Sabarneh; Abedalmajeed Nasereddin; Suheir Ereqat
Journal:  J Clin Lab Anal       Date:  2021-09-08       Impact factor: 2.352

6.  Relationship between MTHFR C677T and A1298C gene polymorphisms and complications of type 2 diabetes mellitus in an Emirati population.

Authors:  Sarah W El Hajj Chehadeh; Herbert F Jelinek; Wael A Al Mahmeed; Guan K Tay; Unini O Odama; Gehad E B Elghazali; Habiba S Al Safar
Journal:  Meta Gene       Date:  2016-04-17

7.  Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case-control study and a meta-analysis.

Authors:  Hsueh-Lu Chang; Guei-Rung Chen; Po-Jen Hsiao; Chih-Chien Chiu; Ming-Cheng Tai; Chung-Cheng Kao; Dung-Jang Tsai; Hao Su; Yu-Hsuan Chen; Wei-Teing Chen; Sui-Lung Su
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.